Security Snapshot

MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) Institutional Ownership

CUSIP: 56565P103

13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

59

Shares (Excl. Options)

24.41MFull value: 24,407,520 · shares · 30 Sep 2026

Price

$10.19

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,699,305
Value change
-$21,905,402
Number of holders
59
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
55,600,941
SEC-reported price per share
$7.97
Insider filing price
$7.97
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • MPLT - MapLight Therapeutics, Inc. - COMMON STOCK is tracked under CUSIP 56565P103.
  • 59 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 105 to 59 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $941.27MFull value: $941,273,092 · USD · 30 Jun 2026
    to
    $248.71MFull value: $248,708,145 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 59 institutions filings for Q3 2026.

Open SEC evidence

Security key

56565P103

13F reference period

Q3 2026

13F holders

59

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
MPLT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Catalyst4, Inc. 50% +4.2% $386,330,234 +$93,009,388 27,536,011 +32% Catalyst4, Inc. 14 Aug 2026
Forbion Growth Opportunities Fund III Cooperatief U.A. 8.4% +19% $45,124,662 +$12,247,646 4,428,328 +37% Forbion Growth Opportunities Fund III Cooperatief U.A. 30 Sep 2026
Pivotal bioVenture Partners Fund II, L.P. 5.5% $40,909,712 2,915,874 Nan Fung Group Holdings Limited 13 Aug 2026
Novo Holdings A/S 4.9% -44% $76,307,767 -$58,512,000 2,086,622 -43% Novo Holdings A/S 30 Jul 2026
T. Rowe Price Investment Management, Inc. 1.7% -81% $9,631,751 -$22,339,965 945,216 -70% T. Rowe Price Investment Management, Inc. 30 Sep 2026
As of 30 Sep 2026, 59 institutional investors reported holding
24.41MFull value: 24,407,520 · shares · 30 Sep 2026
shares of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT). This represents 44% of the company’s total
55.6MFull value: 55,600,941 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
37%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FCPM III SERVICES B.V. 8% 4,428,328 4.3% $45,124,662
GOLDMAN SACHS GROUP INC 6.5% 3,599,556 0% $36,679,475
NOVO HOLDINGS A/S 3.8% 2,086,622 1.4% $21,262,678
Deep Track Capital, LP 2.4% 1,318,101 0.23% $13,431,449
BAKER BROS. ADVISORS LP 2.1% 1,166,763 0.06% $11,889,315
T. Rowe Price Investment Management, Inc. 1.7% 945,216 0.01% $9,632,000
Sanofi 1.6% 912,041 1.5% $9,293,698
5AM Venture Management, LLC 1.3% 741,893 2.5% $7,559,890
Velan Capital Investment Management LP 1.1% 624,703 6.1% $6,365,724
MARSHALL WACE, LLP 1.1% 612,310 0.01% $6,239,438
Pivotal bioVenture Partners Investment Advisor LLC 1.1% 611,446 2.5% $6,230,635
TWO SIGMA INVESTMENTS, LP 0.93% 516,022 0% $5,258,264
GEODE CAPITAL MANAGEMENT, LLC 0.79% 440,731 0% $4,492,445
Point72 Asset Management, L.P. 0.77% 426,261 0.01% $4,343,600
Capital World Investors 0.75% 415,760 0% $4,236,594
VANGUARD CAPITAL MANAGEMENT LLC 0.71% 396,076 0% $4,036,014
Trexquant Investment LP 0.65% 363,736 0.02% $3,706,470
STATE STREET CORP 0.56% 313,586 0% $3,195,441
DAFNA Capital Management LLC 0.28% 155,579 0.34% $1,585,350
TD ASSET MANAGEMENT INC 0.25% 140,888 0% $1,430,013
VANGUARD PORTFOLIO MANAGEMENT LLC 0.22% 120,871 0% $1,231,675
SUPERSTRING CAPITAL MANAGEMENT LP 0.21% 118,304 0.6% $1,205,518
VANGUARD FIDUCIARY TRUST CO 0.21% 116,464 0% $1,186,768
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.15% 83,274 0% $848,562
Quadrature Capital Ltd 0.13% 74,485 0% $759,002

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Headline period
Q3 2026
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 24,407,520 $248,708,145 -$21,905,402 $10.19 59
2026 Q2 26,263,305 $941,273,092 +$72,781,489 $35.84 105
2026 Q1 24,700,477 $502,152,842 +$34,264,805 $20.33 80
2025 Q4 23,065,711 $405,121,994 +$405,061,184 $17.56 74
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .